168 related articles for article (PubMed ID: 33435665)
1. Homobivalent Dopamine D
Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
[TBL] [Abstract][Full Text] [Related]
3. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
4. Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology.
Kopinathan A; Scammells PJ; Lane JR; Capuano B
Future Med Chem; 2016 Jul; 8(11):1349-72. PubMed ID: 27357619
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided development of heterodimer-selective GPCR ligands.
Hübner H; Schellhorn T; Gienger M; Schaab C; Kaindl J; Leeb L; Clark T; Möller D; Gmeiner P
Nat Commun; 2016 Jul; 7():12298. PubMed ID: 27457610
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
[TBL] [Abstract][Full Text] [Related]
7. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
Kaczor AA; Jörg M; Capuano B
J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
[TBL] [Abstract][Full Text] [Related]
8. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
[TBL] [Abstract][Full Text] [Related]
9. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
10. Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer.
Budzinski J; Maschauer S; Kobayashi H; Couvineau P; Vogt H; Gmeiner P; Roggenhofer A; Prante O; Bouvier M; Weikert D
Commun Biol; 2021 Sep; 4(1):1062. PubMed ID: 34508168
[TBL] [Abstract][Full Text] [Related]
11. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a true bivalent dopamine D
Qian M; Ricarte A; Wouters E; Dalton JAR; Risseeuw MDP; Giraldo J; Van Calenbergh S
Eur J Med Chem; 2021 Feb; 212():113151. PubMed ID: 33450620
[TBL] [Abstract][Full Text] [Related]
13. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.
Soriano A; Ventura R; Molero A; Hoen R; Casadó V; Cortés A; Fanelli F; Albericio F; Lluís C; Franco R; Royo M
J Med Chem; 2009 Sep; 52(18):5590-602. PubMed ID: 19711895
[TBL] [Abstract][Full Text] [Related]
14. Evidence against dopamine D1/D2 receptor heteromers.
Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
[TBL] [Abstract][Full Text] [Related]
15. Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors.
Newton CL; Wood MD; Strange PG
PLoS One; 2016; 11(7):e0158808. PubMed ID: 27379794
[TBL] [Abstract][Full Text] [Related]
16. Differential allosteric modulation within dopamine D
Plach M; Schäfer T; Borroto-Escuela DO; Weikert D; Gmeiner P; Fuxe K; Friedland K
Sci Rep; 2019 Nov; 9(1):16312. PubMed ID: 31704949
[TBL] [Abstract][Full Text] [Related]
17. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
[TBL] [Abstract][Full Text] [Related]
18. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
Kühhorn J; Hübner H; Gmeiner P
J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
[TBL] [Abstract][Full Text] [Related]
19. Synthesis toward Bivalent Ligands for the Dopamine D
Qian M; Wouters E; Dalton JAR; Risseeuw MDP; Crans RAJ; Stove C; Giraldo J; Van Craenenbroeck K; Van Calenbergh S
J Med Chem; 2018 Sep; 61(18):8212-8225. PubMed ID: 30180563
[TBL] [Abstract][Full Text] [Related]
20. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
Peterson SM; Pack TF; Caron MG
PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
